A detailed history of Wellington Management Group LLP transactions in Altimmune, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 197,232 shares of ALT stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
197,232
Previous 154,679 27.51%
Holding current value
$1.35 Million
Previous $1.03 Million 17.8%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.5 - $8.1 $234,041 - $344,679
42,553 Added 27.51%
197,232 $1.21 Million
Q2 2024

Aug 13, 2024

SELL
$5.91 - $10.23 $13,208 - $22,864
-2,235 Reduced 1.42%
154,679 $1.03 Million
Q1 2024

May 15, 2024

BUY
$8.22 - $13.81 $1.29 Million - $2.17 Million
156,914 New
156,914 $1.6 Million

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $337M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.